PDCD1 and lymphoproliferative syndrome: Moreover, PD-1 and its ligands, PD-L1 and PD-L2, are overexpressed in Epstein Barr virus-positive lymphoproliferative disorders and are markers of aggressive behavior,10 which necessitates an assessment of the efficacy of PD-1 antibodies in these patients (NCT03258567).